Tag: artificial intelligence in drug discovery industry

  • Artificial Intelligence (AI) In Drug Discovery Market Insights: In-Depth Look at Growth Trends, Market Size, and Opportunities for 2025-2034

    Artificial Intelligence (AI) In Drug Discovery Market Insights: In-Depth Look at Growth Trends, Market Size, and Opportunities for 2025-2034

    2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

    What Are the Primary Drivers Supporting the Market Growth of theArtificial Intelligence (AI) In Drug Discovery Market?

    The surge in the need for personalized medicine is poised to fuel the expansion of artificial intelligence (AI) within the drug discovery market in the future. Personalized medicine classifies as a kind of medication that uses a person’s genetic or protein knowledge to prevent, diagnose or treat diseases. AI holds a pivotal part in the creation of personalized medicines through all pertinent stages of clinical growth and deployment of new customized health goods by determining suitable intervention points and examining their usefulness. For example, in February 2024, it was reported by the Personalized Medicine Coalition, an American professional membership organization, that in 2022, 12 personalized medicines were given the green light by the US Food and Drug Administration (FDA), making up roughly 34% of all newly authorized therapeutic molecular entities. Consequently, the rising need for personalized medicine is propelling the growth of artificial intelligence (AI) in the drug discovery market.

    Get Your Free Sample Report Now – Explore Exclusive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3411&type=smp

    #What Are the Key Projections for the CAGR of the Artificial Intelligence (AI) In Drug Discovery Market From 2025 to 2034?

    In recent times, there has been an exponential surge in the market size of artificial intelligence (AI) used in drug discovery. The market that was worth $1.78 billion in 2024 is expected to expand to $2.34 billion in 2025, reflecting a compound annual growth rate (CAGR) of 31.1%. This substantial growth during the historic period is a result of several factors including the emergence of new markets, rising occurrence of chronic illnesses, the growing preference for AI in achieving cost-effective drug discovery, and increased rigorous quality protocols for drug makers.

    In the upcoming years, the market size of artificial intelligence (AI) in drug discovery is predicted to expand greatly. By 2029, it’s projected to reach $5.98 billion, with a compound annual growth rate (CAGR) of 26.5%. Several factors such as government backing, a surge in healthcare spending and growing use of cloud-based applications and services are attributed to the growth in this forecast period. Key trends within this period include the amalgamation of multi-omics data, implementing AI in target selection and drug screening, the establishment of AI innovation laboratories, and heightened investment in alliances and cooperations.

    You can Directly Purchase the Report Here:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3411

    What Are the Latest Innovations Influencing theArtificial Intelligence (AI) In Drug Discovery Market?

    Prominent organizations in the AI drug delivery market are strategically collaborating to aid in drug research and discovery through AI, which is garnering considerable attention in the AI in drug discovery market. For instance, Atomwise, an American company specializing in artificial intelligence systems, joined forces with Sanofi in August 2022. The goal of this alliance was to identify and examine up to five pharmacological targets using Atomwise’s AI-driven AtomNet technology. Atomwise was awarded a $20 million initial payment from Sanofi to discover, develop, and further the exploration of lead compounds for up to five exclusive Sanofi targets. Sanofi is a healthcare and pharmaceutical company based in France.

    Who Are the Major Industry Players Accelerating Growth in theArtificial Intelligence (AI) In Drug Discovery Market?

    Major companies operating in the artificial intelligence (AI) in drug discovery market include IBM Corporation, Microsoft Corporation, NVIDIA Corporation, Exscientia, Alphabet, Insilico Medicine, Owkin Inc, Xtalpi Inc, Cloud Pharmaceuticals, Shanghai PharmaceuticS, Standigm, Indegene, Intuition Systems, Innoplexus, Takeda Pharmaceutical Company Ltd., RxPrism, Otsuka Pharmaceutical Co. Ltd., China National Pharmaceutical Group Co., Ltd., Jiangsu Hengrui Medicine Co., Ltd, Cipla Limited, Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Ltd., Sun Pharma, Tricog Health Services Pvt. Ltd., Alliance Pharm Pte Ltd., CytoReason, IIPharma, StoneWise, Adagene, GT Apeiron Therapeutics, Xbiome, Accutar Biotech, DeepMind, Renalytix AI, Iktos, Ipsen Pharma, Galderma S.A., BenevolentAI, Deepflare, Novartis, Gero, Ardigen, Botkin, Care Mentor AI, Diagnocat, GNS Healthcare, Merck & Co., Apotex, Pfizer, Gilead Sciences, Roche, Bayer, AbbVie Inc., GlaxoSmithKline, AstraZeneca, Amgen, Sanofi Pasteur, Abbott Laboratories, Teva Canada, Accord Healthcare Inc, Acerus Pharmaceuticals Corporation, AA Pharma Inc, Sanfer, Siegfried Rhein, Atomwise, Inc., Bioage, NuMedii, Envisagenics, Aria Pharmaceuticals, Verge Genomics, Berg LLC, Deep Genomics, Cyclica, IQVIA, Quris, GE Healthcare, Avanade, Group42 Holding Ltd, Ilara Health, Adcock Ingram, Johnson & Johnson, Eurolab, Ranbaxy (SA) (Pty) Ltd, Aspen, Rology, hearX Group, DilenyTech

    Order Your Report Now For A Swift Delivery:

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-drug-discovery-global-market-report

    Which Primary Segments of the Artificial Intelligence (AI) In Drug Discovery Market Are Driving Growth and Industry Transformations?

    The artificial intelligence (AI) in drug discovery market covered in this report is segmented –

    1) By Technology: Context-Aware Processing, Natural Language Processing, Querying Method, Deep Learning

    2) By Drug Type: Small Molecules, Large Molecules

    3) By Therapeutic Type: Metabolic Disease, Cardiovascular Disease, Oncology, Neurodegenerative Diseases, Anti-Infective Diseases, Respiratory Diseases, Other Therapeutics

    4) By End User: Pharmaceutical Companies, Biopharmaceutical Companies, Academic And Research Institutes, Other End-Users

    Subsegments:

    1) By Context-Aware Processing: Contextual Data Integration, Predictive Modeling, Adaptive Learning Systems

    2) By Natural Language Processing (NLP): Text Mining And Analysis, Sentiment Analysis, Drug Interaction Extraction, Clinical Trial Data Analysis

    3) By Querying Method: Semantic Search, Knowledge Graphs, Structured Query Language (SQL) Based Queries

    4) By Deep Learning: Neural Networks, Convolutional Neural Networks (CNNs), Recurrent Neural Networks (RNNs), Reinforcement Learning Applications

    Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

    https://www.thebusinessresearchcompany.com/customise?id=3411&type=smp

    Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of theArtificial Intelligence (AI) In Drug Discovery Market?# Market?

    North America was the largest region in the artificial intelligence (AI) in drug discovery market in 2024. Western Europe was the second largest region in the global artificial intelligence (AI) in drug discovery market share. The regions covered in the artificial intelligence (AI) in drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    Browse Through More Reports Similar to the Global Artificial Intelligence (AI) In Drug Discovery Market 2025, By The Business Research Company:

    AI In Pharma Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/ai-in-pharma-global-market-report

    Automotive Artificial Intelligence Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/automotive-artificial-intelligence-global-market-report

    Artificial Intelligence in Healthcare Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-healthcare-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Artificial Intelligence (AI) In Drug Discovery Trends and Opportunities 2025-2034: A Comprehensive Guide to Growth Insights

    Artificial Intelligence (AI) In Drug Discovery Trends and Opportunities 2025-2034: A Comprehensive Guide to Growth Insights

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    What Factors Are Driving the Anticipated Growth Rate of the Artificial Intelligence (AI) In Drug Discovery Market Through 2034?

    The artificial intelligence (AI) in drug discovery market has grown exponentially. It is forecasted to rise from $1.78 billion in 2024 to $2.34 billion in 2025, reflecting a CAGR of 31.1%. Growth has been fueled by increasing AI adoption for cost-efficient drug discovery, rising chronic disease prevalence, regulatory compliance needs, and economic expansion in emerging markets.

    The artificial intelligence (AI) in drug discovery market is projected to experience exponential growth, expected to reach $5.98 billion by 2029 at a compound annual growth rate (CAGR) of 26.5%. The anticipated growth is driven by government support, rising healthcare expenditures, and the growing adoption of cloud-based applications. Key trends expected during this period include the integration of multi-omics data, the application of AI in target selection and drug screening, the establishment of AI innovation labs, and increasing investments in partnerships.

    What Key Drivers Are Accelerating the Growth of the artificial intelligence (ai) in drug discovery Market During the Forecast Period?

    The increasing demand for personalized medicine is expected to drive the growth of artificial intelligence (AI) in the drug discovery market. Personalized medicine aims to prevent, detect, or treat diseases using individual genetic or protein information. AI plays a crucial role in personalized medicine by identifying potential intervention targets and testing new therapies. In 2022, the FDA approved 12 personalized medicines, accounting for 34% of all newly approved therapeutic drugs. As a result, the growing demand for personalized medicine is expected to drive the growth of AI in drug discovery.

    Request Your Free Artificial Intelligence (AI) In Drug Discovery Market Report Sample Now!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3411&type=smp

    Who Are the Major Industry Leaders Accelerating Growth in the Artificial Intelligence (AI) In Drug Discovery Market?

    Major companies operating in the artificial intelligence (AI) in drug discovery market include:

    • IBM Corporation_x000D_

    • Microsoft Corporation_x000D_

    • NVIDIA Corporation_x000D_

    • Exscientia_x000D_

    • Alphabet_x000D_

    Which Current Trends Are Having the Most Impact on the Artificial Intelligence (AI) In Drug Discovery Market?

    Leading companies in the AI-driven drug delivery market are forming strategic collaborations to advance AI-based drug research and discovery. AI is gaining traction in pharmaceutical innovation, enabling faster and more precise drug development. For instance, in August 2022, Atomwise, a US-based AI-driven drug discovery company, partnered with Sanofi to computationally identify and investigate up to five pharmacological targets using its AtomNet AI technology. Under this agreement, Sanofi provided an upfront payment of $20 million to Atomwise to facilitate the development of lead compounds for exclusive targets.

    Pre-order Your Report for Quick and Easy Delivery!

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-drug-discovery-global-market-report

    What Are the Key Components of the Artificial Intelligence (AI) In Drug Discovery Market, and How Do Its Segments Perform?

    The artificial intelligence (AI) in drug discovery market covered in this report is segmented –

    1) By Technology: Context-Aware Processing, Natural Language Processing, Querying Method, Deep Learning

    2) By Drug Type: Small Molecules, Large Molecules

    3) By Therapeutic Type: Metabolic Disease, Cardiovascular Disease, Oncology, Neurodegenerative Diseases, Anti-Infective Diseases, Respiratory Diseases, Other Therapeutics

    4) By End User: Pharmaceutical Companies, Biopharmaceutical Companies, Academic And Research Institutes, Other End-Users

    Subsegments:

    1) By Context-Aware Processing: Contextual Data Integration, Predictive Modeling, Adaptive Learning Systems

    2) By Natural Language Processing (NLP): Text Mining And Analysis, Sentiment Analysis, Drug Interaction Extraction, Clinical Trial Data Analysis

    3) By Querying Method: Semantic Search, Knowledge Graphs, Structured Query Language (SQL) Based Queries

    4) By Deep Learning: Neural Networks, Convolutional Neural Networks (CNNs), Recurrent Neural Networks (RNNs), Reinforcement Learning Applications

    Which Regions Are Key Players in the Growth of the Artificial Intelligence (AI) In Drug Discovery Market?

    North America was the largest region in the artificial intelligence (AI) in drug discovery market in 2024. Western Europe was the second largest region in the global artificial intelligence (AI) in drug discovery market share. The regions covered in the artificial intelligence (AI) in drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    How Is the Scope and Reach of the Artificial Intelligence (AI) In Drug Discovery Market Defined?

    Artificial intelligence (AI) is a simulation of human intelligence in machines that are programmed to think and behave like humans. AI helps to complete the job quickly and with relatively few errors.

    Browse Through More Similar Reports By The Business Research Company:

    AI In Pharma Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/ai-in-pharma-global-market-report

    Automotive Artificial Intelligence Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/automotive-artificial-intelligence-global-market-report

    Artificial Intelligence in Healthcare Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-healthcare-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Artificial Intelligence (AI) In Drug Discovery Trends and Opportunities 2025-2034: A Comprehensive Guide to Growth Insights

    Artificial Intelligence (AI) In Drug Discovery Trends and Opportunities 2025-2034: A Comprehensive Guide to Growth Insights

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    What Factors Are Driving the Anticipated Growth Rate of the Artificial Intelligence (AI) In Drug Discovery Market Through 2034?

    The artificial intelligence (AI) in drug discovery market has grown exponentially. It is forecasted to rise from $1.78 billion in 2024 to $2.34 billion in 2025, reflecting a CAGR of 31.1%. Growth has been fueled by increasing AI adoption for cost-efficient drug discovery, rising chronic disease prevalence, regulatory compliance needs, and economic expansion in emerging markets.

    The artificial intelligence (AI) in drug discovery market is projected to experience exponential growth, expected to reach $5.98 billion by 2029 at a compound annual growth rate (CAGR) of 26.5%. The anticipated growth is driven by government support, rising healthcare expenditures, and the growing adoption of cloud-based applications. Key trends expected during this period include the integration of multi-omics data, the application of AI in target selection and drug screening, the establishment of AI innovation labs, and increasing investments in partnerships.

    What Key Drivers Are Accelerating the Growth of the artificial intelligence (ai) in drug discovery Market During the Forecast Period?

    The increasing demand for personalized medicine is expected to drive the growth of artificial intelligence (AI) in the drug discovery market. Personalized medicine aims to prevent, detect, or treat diseases using individual genetic or protein information. AI plays a crucial role in personalized medicine by identifying potential intervention targets and testing new therapies. In 2022, the FDA approved 12 personalized medicines, accounting for 34% of all newly approved therapeutic drugs. As a result, the growing demand for personalized medicine is expected to drive the growth of AI in drug discovery.

    Request Your Free Artificial Intelligence (AI) In Drug Discovery Market Report Sample Now!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3411&type=smp

    Who Are the Major Industry Leaders Accelerating Growth in the Artificial Intelligence (AI) In Drug Discovery Market?

    Major companies operating in the artificial intelligence (AI) in drug discovery market include:

    • IBM Corporation_x000D_

    • Microsoft Corporation_x000D_

    • NVIDIA Corporation_x000D_

    • Exscientia_x000D_

    • Alphabet_x000D_

    Which Current Trends Are Having the Most Impact on the Artificial Intelligence (AI) In Drug Discovery Market?

    Leading companies in the AI-driven drug delivery market are forming strategic collaborations to advance AI-based drug research and discovery. AI is gaining traction in pharmaceutical innovation, enabling faster and more precise drug development. For instance, in August 2022, Atomwise, a US-based AI-driven drug discovery company, partnered with Sanofi to computationally identify and investigate up to five pharmacological targets using its AtomNet AI technology. Under this agreement, Sanofi provided an upfront payment of $20 million to Atomwise to facilitate the development of lead compounds for exclusive targets.

    Pre-order Your Report for Quick and Easy Delivery!

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-drug-discovery-global-market-report

    What Are the Key Components of the Artificial Intelligence (AI) In Drug Discovery Market, and How Do Its Segments Perform?

    The artificial intelligence (AI) in drug discovery market covered in this report is segmented –

    1) By Technology: Context-Aware Processing, Natural Language Processing, Querying Method, Deep Learning

    2) By Drug Type: Small Molecules, Large Molecules

    3) By Therapeutic Type: Metabolic Disease, Cardiovascular Disease, Oncology, Neurodegenerative Diseases, Anti-Infective Diseases, Respiratory Diseases, Other Therapeutics

    4) By End User: Pharmaceutical Companies, Biopharmaceutical Companies, Academic And Research Institutes, Other End-Users

    Subsegments:

    1) By Context-Aware Processing: Contextual Data Integration, Predictive Modeling, Adaptive Learning Systems

    2) By Natural Language Processing (NLP): Text Mining And Analysis, Sentiment Analysis, Drug Interaction Extraction, Clinical Trial Data Analysis

    3) By Querying Method: Semantic Search, Knowledge Graphs, Structured Query Language (SQL) Based Queries

    4) By Deep Learning: Neural Networks, Convolutional Neural Networks (CNNs), Recurrent Neural Networks (RNNs), Reinforcement Learning Applications

    Which Regions Are Key Players in the Growth of the Artificial Intelligence (AI) In Drug Discovery Market?

    North America was the largest region in the artificial intelligence (AI) in drug discovery market in 2024. Western Europe was the second largest region in the global artificial intelligence (AI) in drug discovery market share. The regions covered in the artificial intelligence (AI) in drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    How Is the Scope and Reach of the Artificial Intelligence (AI) In Drug Discovery Market Defined?

    Artificial intelligence (AI) is a simulation of human intelligence in machines that are programmed to think and behave like humans. AI helps to complete the job quickly and with relatively few errors.

    Browse Through More Similar Reports By The Business Research Company:

    AI In Pharma Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/ai-in-pharma-global-market-report

    Automotive Artificial Intelligence Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/automotive-artificial-intelligence-global-market-report

    Artificial Intelligence in Healthcare Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-healthcare-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Artificial Intelligence (AI) In Drug Discovery Trends and Opportunities 2025-2034: A Comprehensive Guide to Growth Insights

    Artificial Intelligence (AI) In Drug Discovery Trends and Opportunities 2025-2034: A Comprehensive Guide to Growth Insights

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    What Factors Are Driving the Anticipated Growth Rate of the Artificial Intelligence (AI) In Drug Discovery Market Through 2034?

    The artificial intelligence (AI) in drug discovery market has grown exponentially. It is forecasted to rise from $1.78 billion in 2024 to $2.34 billion in 2025, reflecting a CAGR of 31.1%. Growth has been fueled by increasing AI adoption for cost-efficient drug discovery, rising chronic disease prevalence, regulatory compliance needs, and economic expansion in emerging markets.

    The artificial intelligence (AI) in drug discovery market is projected to experience exponential growth, expected to reach $5.98 billion by 2029 at a compound annual growth rate (CAGR) of 26.5%. The anticipated growth is driven by government support, rising healthcare expenditures, and the growing adoption of cloud-based applications. Key trends expected during this period include the integration of multi-omics data, the application of AI in target selection and drug screening, the establishment of AI innovation labs, and increasing investments in partnerships.

    What Key Drivers Are Accelerating the Growth of the artificial intelligence (ai) in drug discovery Market During the Forecast Period?

    The increasing demand for personalized medicine is expected to drive the growth of artificial intelligence (AI) in the drug discovery market. Personalized medicine aims to prevent, detect, or treat diseases using individual genetic or protein information. AI plays a crucial role in personalized medicine by identifying potential intervention targets and testing new therapies. In 2022, the FDA approved 12 personalized medicines, accounting for 34% of all newly approved therapeutic drugs. As a result, the growing demand for personalized medicine is expected to drive the growth of AI in drug discovery.

    Request Your Free Artificial Intelligence (AI) In Drug Discovery Market Report Sample Now!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3411&type=smp

    Who Are the Major Industry Leaders Accelerating Growth in the Artificial Intelligence (AI) In Drug Discovery Market?

    Major companies operating in the artificial intelligence (AI) in drug discovery market include:

    • IBM Corporation_x000D_

    • Microsoft Corporation_x000D_

    • NVIDIA Corporation_x000D_

    • Exscientia_x000D_

    • Alphabet_x000D_

    Which Current Trends Are Having the Most Impact on the Artificial Intelligence (AI) In Drug Discovery Market?

    Leading companies in the AI-driven drug delivery market are forming strategic collaborations to advance AI-based drug research and discovery. AI is gaining traction in pharmaceutical innovation, enabling faster and more precise drug development. For instance, in August 2022, Atomwise, a US-based AI-driven drug discovery company, partnered with Sanofi to computationally identify and investigate up to five pharmacological targets using its AtomNet AI technology. Under this agreement, Sanofi provided an upfront payment of $20 million to Atomwise to facilitate the development of lead compounds for exclusive targets.

    Pre-order Your Report for Quick and Easy Delivery!

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-drug-discovery-global-market-report

    What Are the Key Components of the Artificial Intelligence (AI) In Drug Discovery Market, and How Do Its Segments Perform?

    The artificial intelligence (AI) in drug discovery market covered in this report is segmented –

    1) By Technology: Context-Aware Processing, Natural Language Processing, Querying Method, Deep Learning

    2) By Drug Type: Small Molecules, Large Molecules

    3) By Therapeutic Type: Metabolic Disease, Cardiovascular Disease, Oncology, Neurodegenerative Diseases, Anti-Infective Diseases, Respiratory Diseases, Other Therapeutics

    4) By End User: Pharmaceutical Companies, Biopharmaceutical Companies, Academic And Research Institutes, Other End-Users

    Subsegments:

    1) By Context-Aware Processing: Contextual Data Integration, Predictive Modeling, Adaptive Learning Systems

    2) By Natural Language Processing (NLP): Text Mining And Analysis, Sentiment Analysis, Drug Interaction Extraction, Clinical Trial Data Analysis

    3) By Querying Method: Semantic Search, Knowledge Graphs, Structured Query Language (SQL) Based Queries

    4) By Deep Learning: Neural Networks, Convolutional Neural Networks (CNNs), Recurrent Neural Networks (RNNs), Reinforcement Learning Applications

    Which Regions Are Key Players in the Growth of the Artificial Intelligence (AI) In Drug Discovery Market?

    North America was the largest region in the artificial intelligence (AI) in drug discovery market in 2024. Western Europe was the second largest region in the global artificial intelligence (AI) in drug discovery market share. The regions covered in the artificial intelligence (AI) in drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    How Is the Scope and Reach of the Artificial Intelligence (AI) In Drug Discovery Market Defined?

    Artificial intelligence (AI) is a simulation of human intelligence in machines that are programmed to think and behave like humans. AI helps to complete the job quickly and with relatively few errors.

    Browse Through More Similar Reports By The Business Research Company:

    AI In Pharma Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/ai-in-pharma-global-market-report

    Automotive Artificial Intelligence Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/automotive-artificial-intelligence-global-market-report

    Artificial Intelligence in Healthcare Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-healthcare-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Artificial Intelligence (AI) In Drug Discovery Market Insights 2025-2034: Growth Dynamics, Trends, and Strategic Opportunities

    Artificial Intelligence (AI) In Drug Discovery Market Insights 2025-2034: Growth Dynamics, Trends, and Strategic Opportunities

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    What fueled the previous growth in the artificial intelligence (ai) in drug discovery market?

    The market size for artificial intelligence (AI) used in drug discovery has seen significant expansion in the previous years. It is predicted to increase from $1.78 billion in 2024 to $2.34 billion in 2025, with a compound annual growth rate (CAGR) of 31.1%. The ascent during the historic period can be attributed to growth in emerging markets, escalating occurrences of chronic illnesses, the heightened usage of AI for cost-effective drug discovery, and stricter quality regulations imposed on drug manufacturers.

    What will be the artificial intelligence (ai) in drug discovery market size in the future?

    Predictions indicate substantial expansion in the artificial intelligence (AI) in the drug discovery market in the forthcoming years, expecting a leap to $5.98 billion by 2029, boasting a CAGR of 26.5%. It’s the escalation in government backing, amplified expenditure in healthcare, and mounting adoption of cloud-based services and applications that are purveying this prospective growth in the stated period. The imminent trends include fusion of multi-omics data, applying AI in handpicking targeted drugs, leveraging AI in drug screening processes, the inception of AI innovation labs, and a surge in investments towards partnerships and cooperation.

    Get your artificial intelligence (ai) in drug discovery market report here!

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-drug-discovery-global-market-report

    What main drivers are fueling expansion in the artificial intelligence (ai) in drug discovery market?

    The surge in requisition for personalized medicine is projected to spur the advancement of artificial intelligence (AI) in the drug discovery market. Personalized medicine, which employs an individual’s genes or proteins to prevent, detect, or address disease, is where AI can play a significant role. AI’s importance is particularly evident in the development and administration of new personalized health products, where it helps in identifying suitable intervention targets and assessing their usefulness. In February 2024, the Personalized Medicine Coalition, a professional membership organization based in the US, shared that in 2022, the US Food and Drug Administration (FDA) had greenlit 12 personalized medicines. This figure represents roughly 34% of all the newly approved therapeutic molecular entities. Consequently, the rising demand for personalized medicine fuels the expansion of AI in the drug discovery market.

    What key areas define the segmentation of the global artificial intelligence (ai) in drug discovery market?

    The artificial intelligence (AI) in drug discovery market covered in this report is segmented –

    1) By Technology: Context-Aware Processing, Natural Language Processing, Querying Method, Deep Learning

    2) By Drug Type: Small Molecules, Large Molecules

    3) By Therapeutic Type: Metabolic Disease, Cardiovascular Disease, Oncology, Neurodegenerative Diseases, Anti-Infective Diseases, Respiratory Diseases, Other Therapeutics

    4) By End User: Pharmaceutical Companies, Biopharmaceutical Companies, Academic And Research Institutes, Other End-Users

    Subsegments:

    1) By Context-Aware Processing: Contextual Data Integration, Predictive Modeling, Adaptive Learning Systems

    2) By Natural Language Processing (NLP): Text Mining And Analysis, Sentiment Analysis, Drug Interaction Extraction, Clinical Trial Data Analysis

    3) By Querying Method: Semantic Search, Knowledge Graphs, Structured Query Language (SQL) Based Queries

    4) By Deep Learning: Neural Networks, Convolutional Neural Networks (CNNs), Recurrent Neural Networks (RNNs), Reinforcement Learning Applications

    Get your free sample now – explore exclusive market insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3411&type=smp

    Who are the dominant players expanding their reach in the artificial intelligence (ai) in drug discovery market?

    Major companies operating in the artificial intelligence (AI) in drug discovery market include IBM Corporation, Microsoft Corporation, NVIDIA Corporation, Exscientia, Alphabet, Insilico Medicine, Owkin Inc, Xtalpi Inc, Cloud Pharmaceuticals, Shanghai PharmaceuticS, Standigm, Indegene, Intuition Systems, Innoplexus, Takeda Pharmaceutical Company Ltd., RxPrism, Otsuka Pharmaceutical Co. Ltd., China National Pharmaceutical Group Co., Ltd., Jiangsu Hengrui Medicine Co., Ltd, Cipla Limited, Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Ltd., Sun Pharma, Tricog Health Services Pvt. Ltd., Alliance Pharm Pte Ltd., CytoReason, IIPharma, StoneWise, Adagene, GT Apeiron Therapeutics, Xbiome, Accutar Biotech, DeepMind, Renalytix AI, Iktos, Ipsen Pharma, Galderma S.A., BenevolentAI, Deepflare, Novartis, Gero, Ardigen, Botkin, Care Mentor AI, Diagnocat, GNS Healthcare, Merck & Co., Apotex, Pfizer, Gilead Sciences, Roche, Bayer, AbbVie Inc., GlaxoSmithKline, AstraZeneca, Amgen, Sanofi Pasteur, Abbott Laboratories, Teva Canada, Accord Healthcare Inc, Acerus Pharmaceuticals Corporation, AA Pharma Inc, Sanfer, Siegfried Rhein, Atomwise, Inc., Bioage, NuMedii, Envisagenics, Aria Pharmaceuticals, Verge Genomics, Berg LLC, Deep Genomics, Cyclica, IQVIA, Quris, GE Healthcare, Avanade, Group42 Holding Ltd, Ilara Health, Adcock Ingram, Johnson & Johnson, Eurolab, Ranbaxy (SA) (Pty) Ltd, Aspen, Rology, hearX Group, DilenyTech

    How are evolving market trends shaping artificial intelligence (ai) in drug discovery Strategies?

    Significant players in the AI drug delivery market are employing strategic partnerships for research and drug discovery utilising AI, leading to a surge in popularity in the AI drug discovery market. For example, Atomwise, an American artificial intelligence systems company, established a partnership with Sanofi in August 2022. This collaboration focused on using Atomwise’s AI-powered AtomNet technology to computationally identify and examine up to five pharmacological targets. Atomwise was paid an upfront amount of $20 million by Sanofi to discover, formulate, and push forward lead compounds for up to five exclusive Sanofi targets. Sanofi is a French organization specializing in pharmaceuticals and healthcare.

    Unlock exclusive market insights – purchase your research report now for a swift delivery!

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3411

    Which regions are emerging as leaders in the artificial intelligence (ai) in drug discovery market?

    North America was the largest region in the artificial intelligence (AI) in drug discovery market in 2024. Western Europe was the second largest region in the global artificial intelligence (AI) in drug discovery market share. The regions covered in the artificial intelligence (AI) in drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    Browse Through More Similar Reports By The Business Research Company:

    AI In Pharma Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/ai-in-pharma-global-market-report

    Automotive Artificial Intelligence Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/automotive-artificial-intelligence-global-market-report

    Artificial Intelligence in Healthcare Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-healthcare-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on: